The prognostic implications of primary tumor location on recurrence in early-stage colorectal cancer with no associated risk factors
Recently, several reports have suggested that tumor location serves as a prognostic biomarker in advanced colorectal cancer. However, the prognostic implication of tumor location in patients with early-stage colorectal cancer remains unclear. This study was aimed to examine the prognostic implication of tumor location in patients with early-stage colorectal cancer.
Patients with stage I and low-risk stage II colorectal cancer, treated with radical surgery in a hospital setting between May 2003 and September 2014, were retrospectively reviewed. Patients who underwent (neo) adjuvant chemotherapy and/or radiotherapy and whose microsatellite instability (MSI) status was lacked were excluded. Distal colon cancer was defined as tumors located from the splenic flexure colon to the sigmoid colon.
A total of 712 patients were included in this study. Of these patients, 23 (3.2%) had a recurrence at a median follow-up time of 46 months. The tumor recurrence rate was significantly low in patients with proximal colon cancer. In the multivariate analysis, tumors located in the distal colon or rectum (distal colon, hazard ratio [HR] 9.213, P = 0.035; rectum, HR 15.366, P = 0.009) and T3 tumors (HR 4.590, P = 0.017) were related to tumor recurrence. A higher prevalence of tumor recurrence was found in patients with two recurrence factors than those who had only one factor or none (P < 0.001).
Tumor location, as well as T stage, had prognostic implication in patients with early-stage colorectal cancer. Validation of our results is needed in a large cohort with genetic characterization.
KeywordsEarly colorectal cancer Tumor location Tumor recurrence Risk factors
Compliance with ethical standards
This retrospective study was approved by the Ethics Review Board at our institution (SNUBH IRB No. B-1709-420-110).
Conflict of interest
The authors declare that they have no conflicts of interest.
- 4.Lee BI, Hong SP, Kim SE, Kim SH, Kim HS, Hong SN, Yang DH, Shin SJ, Lee SH, Park DI, Kim YH, Kim HJ, Yang SK, Kim HJ, Jeon HJ, Multi-Society Task Force for Development of Guidelines for Colorectal Polyp Screening, Surveillance and Management (2012) Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc 45(1):25–43CrossRefPubMedPubMedCentralGoogle Scholar
- 7.National Comprehensive Cancer Network. Colon cancer (Version 2. 2017). Accessed March 13, 2017. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf
- 10.Ishihara S, Murono K, Sasaki K et al (2017) Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetastatic colon cancers: a multicenter retrospective study using a propensity score analysis. [Epub ahead of print] Ann Surg. https://doi.org/10.1097/SLA.0000000000002206
- 12.Sasaki K, Andreatos N, Margonis GA, He J, Weiss M, Johnston F, Wolfgang C, Antoniou E, Pikoulis E, Pawlik TM (2016) The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis. J Surg Oncol 114(7):803–809CrossRefPubMedGoogle Scholar
- 14.Kang SI, Kim DW, Cho JY, Park J, Lee KH, Son IT, Oh HK, Kang SB (2017) Is MRI of the liver needed during routine preoperative workup for colorectal cancer? Dis Colon rectum 60(9):936–944Google Scholar
- 15.Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58(22):5248–5257PubMedGoogle Scholar
- 27.Chiang JM, Hsieh PS, Chen JS, Tang R, You JF, Yeh CY (2014) Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol 30(12):197. https://doi.org/10.1186/1477-7819-12-197 CrossRefGoogle Scholar